Update
FDA approves first US biosimilar from Sandoz
The FDA on Friday morning approved Sandoz’s Zarxio (filgrastim-sndz), the first biosimilar product approved in the US.
Update
The FDA on Friday morning approved Sandoz’s Zarxio (filgrastim-sndz), the first biosimilar product approved in the US.
Chicago-based Rottendorf Pharmaceuticals, a top 20 contract development and manufacturing organization (CDMO), has signed three formulation development projects and two commercial transfer projects with multiple top pharma and biotech companies in the...
Icon has agreed to pay $120m for market access company MediMedia.
ABC Laboratories has agreed to provide privately-owned cancer vaccine firm Immunophotonics with development services in exchange for company stock.